KVUE - Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health.
As of Nov 13, 2026: spot at $21.98, ATM IV 76.2%, max pain $19.00, GEX (assumed dealer book) $143.3K of delta per 1% move.
Exposures are the assumed dealer book over the expirations within 30 days of the session, or the first four when none are (4 expirations, through Dec 11, 2026), as of Nov 13, 2026. Assumes dealers are long the calls and short the puts, a share p of open interest each - here 100% of open interest (the GEX page sets the share). A date without a stored exposure is a gap; a value marked * is partial, averaged over fewer days, or may include contracts expiring that day or of an unreadable expiration: its reason is printed beside it.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Market Cap
- $37.09B
- P/E Ratio
- 21.95
- Beta
- 0.45
- 52-Week Range
- 15.94-20.13
- Dividend Yield
- $0.83
- CEO
- Kirk L. Perry
- Employees
- 21,890
- IPO Date
- May 4, 2023
- Exchange
- NYSE
What KVUE Looks Like to Options Traders Today
IV rank of 85.3% signals elevated pricing relative to the 1-year history, conditions that typically favor premium-selling structures (credit spreads, iron condors, covered calls); the assumed dealer book's GEX is positive ($143.3K of delta per 1% move): its hedging leans against the trend, damping realized volatility where real dealers are positioned like the book; the 25-delta skew (-0.120) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The KVUE overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.